Description
| Summary: | Morgan Life Sciences was a biotechnology firm headquartered in Waltham, Massachusetts. Initially, it focused on generic and over-the-counter medications, which it manufactured and distributed to drugstores and supermarket chains. Morgan completed a successful initial public offering in 1994, but by the late 1990s, the generics market had become increasingly competitive. Morgan steadily lost ground as its larger, low-cost competitors pushed prices relentlessly downward. This study explains how CEO Wendy Shaw set about transforming the fortunes of the company.
|
|---|
| Item Description: | Originally Published in: Flaumenhaft, B., & Bagley, C. E. (2008). Morgan Life Sciences. 08-021. New Haven, CT: Yale School of Management, Yale University. |
|---|
| Physical Description: | 1 online resource : illustrations (black and white, and colour). |
|---|
| ISBN: | 9781473973343 (ebook) : |
|---|